Heading into this midterm election year, the cost of health care tops the public’s economic anxieties and more than 4 in 10 voters say the issue will have a major impact on their vote, this KFF Health Tracking poll finds.
NOCD launched a new parent brand, Noto, and acquired PTSD provider Rebound Health to expand its virtual, specialty therapy model beyond OCD into other complex mental health conditions. The post NOCD Launches Parent Brand Noto, Acquires PTSD Provider Rebound Health appeared first on MedCity News.
Climatic, a new wellness startup, emerged from stealth with a $10 million seed round for the non-prescription inhalant it’s developing, which is designed to support daily lung health. The company aims to create a new category of preventive lung care, mainly for athletes and health-conscious consumers. The post Climatic Emerges from Stealth With $10M to…
By GEORGE BEAUREGARD Fifteen months ago, I wrote in The Health Care Blog about the “incoming tide” of early-onset cancer. At that time, the global rise in the incidence of early-onset cancer in younger people that had occurred over three decades had been noticed and was being monitored by researchers, scientists, and other healthcare professionals. Articles on…
This analysis assesses the potential reach of the latest expansion of the Mexico City Policy, which is now part of the Promoting Human Flourishing in Foreign Assistance (PHFFA) Policy.
The 15 drugs selected for the Centers for Medicare and Medicaid Services drug price negotiation program accounted for about $27 billion in total prescription spending under Medicare Parts B and D. But this revenue from Medicare makes up a small percentage of each drug manufacturer’s total sales. The post With CMS’s New List of Meds…
From CMS yesterday: On January 27, 2026, CMS announced the selection of the below list of 15 drugs payable under Medicare Part B and/or covered under Medicare Part D for the third cycle of negotiations (initial price applicability year 2028), based on total expenditures for drugs payable under Part B and/or covered under Part D…
The main question about health bots is accuracy and the trust or distrust that it engenders among users as a result. One journalist from the Washington Post and a strategic advisor to CMS had wildly differing experiences. The post WaPo Columnist and CMS Official Provide Dueling Narratives of ChatGPT Health appeared first on MedCity News.
Nearly 53 million prior authorization requests were submitted to Medicare Advantage insurers on behalf of Medicare Advantage enrollees in 2024, of which 4.1 million (7.7%) were denied. Just 11.5% of denied requests were appealed, though 80.7% of appeals overturned the initial denial in Medicare Advantage. Substantially fewer prior authorization requests were made in traditional Medicare,…
As RWE continues to influence the future of drug development, pharma companies will inevitably encounter hurdles. But with the right approach, they can be overcome to unlock critical insights and bring better therapies to patients faster. The post Harnessing RWE for Post-Pandemic Healthcare: Accelerating Drug Development with Real-World Data appeared first on MedCity News.